Please login to the form below

Not currently logged in

Novartis continues to expand its NHS eyecare partnerships

Will work with Plymouth Hospitals NHS Trust to improve patient outcomes

Novartis and NHS Plymouth Hospitals Trust MTC

Novartis and Plymouth Hospitals NHS Trust have joined forces to improve macular disease care with the launch of a new treatment centre.

The partnership adds to the growing list of Novartis' NHS eyecare collaborations, as part of which it has set up several clinics across the UK in the last few years.

Its new centre in the south of England will see care move toward a nurse and optometrist-led clinical model to improve quality and punctuality of care for patients who require regular monthly or bi-monthly intra-ocular injections. 

Hugh O'Dowd, Novartis' general manager and president for the UK and Ireland, said: “We are committed to working with the NHS in long-term partnerships to help ensure patients are getting timely access to the care they require.

“We've set up this joint working project with the Royal Eye Infirmary to deliver greater accessibility and increased capacity with the aim of providing a more individualised approach to patient care.”

The collaboration was formed in the wake of a patient satisfaction survey that found the Royal Eye Infirmary (REI) unable to provide timely treatment and reviews to all patients.

Novartis said the newly-redesigned macular service at the REI will not only be able to cope with current service demand, but even have capacity to further increase access through the implementation of a virtual clinic scheme.

Dr Tomas Cudrnak, consultant ophthalmologist at the Plymouth Hospitals NHS Trust, said: “We are aiming to concentrate on delivering an unprecedented effectiveness and efficiency to improve visual outcomes of offered treatments.”

Stable patients are to be monitored remotely through the virtual clinics and a new online patient record programme in a bid to streamline current clinical pathways and so improve the expedience of patient care.

In addition to the Plymouth macular treatment centre, Novartis has established local eyecare clinics in Bristol and Cardiff and introduced a mobile eye unit for Surrey, Hampshire and Berkshire.

Article by
Rebecca Clifford

28th January 2016

From: Healthcare



Featured jobs

Subscribe to our email news alerts


Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...